BIOWEG
Germany
- Quakenbrück, Niedersachsen
- 17/09/2025
- Series A
- $18,970,160
BIOWEG, founded in 2019 in Germany, is a purpose-driven organization powered by conscious ChemDesign.
We match Bio-innovation to business problems. We explore and combine biotechnology, material science, and molecular simulation learning to create advanced sustainable bio-based high-performance ingredients.
Our ingredients are 100% animal free, globally scalable, and sustainably produced without harsh chemicals.
We work with results-oriented, forward-thinking companies, and consumer brands with global scale in the cosmetics, personal care, nutraceuticals, agricultural coatings, and food/beverage sectors who desire highly differentiated and sustainable science-based ingredient technologies.
- Industry Biotechnology Research
- Website https://bioweg.com/
- LinkedIn https://www.linkedin.com/company/bioweg/
Related People
Prateek M.Founder
Germany -
Düsseldorf, North Rhine-Westphalia
Entrepreneur and CEO with a passion for impact-driven businesses. BIOWEG offers fossil fuel free Ingredients for FMCG and Agricuture industry.
At BIOWEG, we combat microplastic pollution through zero-waste circular processes, biotech, fermentation, formulations and green chemistry.
Previously, I had worked in strategy consulting, policy making, lobbying and co-founded and worked with other startups. My academic background includes a Ph.D. from the Max Planck Society in Germany, where I had the privilege to work under the direct supervision of Nobel laureate Prof. Christiane Nüsslein-Volhard.
RenoFi | $22,000,000 | (Mar 4, 2026)
Worldscape | Undisclosed Amount | (Mar 4, 2026)
MightyFly | $10,000,000 | (Mar 4, 2026)
Qura | $1,739,595 | (Mar 4, 2026)
KeyCare | $27,400,000 | (Mar 4, 2026)
Devotion(US) | $4,000,000 | (Mar 4, 2026)
Burst | $2,100,000 | (Mar 4, 2026)
JetStream Security Inc. | $34,000,000 | (Mar 4, 2026)
Escargot | $2,750,000 | (Mar 4, 2026)
EGI Battery | $10,000,000 | (Mar 4, 2026)
Bindbridge | $3,800,000 | (Mar 4, 2026)
Inhouse | $5,000,000 | (Mar 3, 2026)